Atrial septal defect 2

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Cardiovascular Diseases: 91362
- Heart Diseases: 26014
  - Congenital Heart Defects: 8917
    - Heart Septal Defects: 41
      - Atrial Heart Septal Defects: 2183
        Atrial septal defect 2: 6
- Cardiovascular Abnormalities: 452
  - Congenital Heart Defects: 8917
    - Heart Septal Defects: 41
      - Atrial Heart Septal Defects: 2183
        Atrial septal defect 2: 6
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Cardiovascular Abnormalities: 452
    - Congenital Heart Defects: 8917
      - Heart Septal Defects: 41
        Atrial Heart Septal Defects: 2183
        Atrial septal defect 2: 6

Related Diseases

1.	Patent Foramen Ovale
2.	Tetralogy of Fallot (Fallot Tetralogy)
3.	Mitral Valve Stenosis (Mitral Stenosis)
4.	Mitral Valve Prolapse
5.	Mitral Valve Insufficiency (Mitral Regurgitation)

Experts

1.	Buch, Eric: 1 article (12/2019)
2.	Gallotti, Roberto G: 1 article (12/2019)
3.	Moore, Jeremy P: 1 article (12/2019)
4.	Shannon, Kevin M: 1 article (12/2019)
5.	Agarwal, R: 1 article (09/2010)
6.	Agarwal, S K: 1 article (09/2010)
7.	Kalita, J: 1 article (09/2010)
8.	Misra, U K: 1 article (09/2010)
9.	Pandey, S: 1 article (09/2010)
10.	Bartus, Krzysztof: 1 article (01/2008)

Therapies and Procedures

1.	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/01/2010 - "Coronary artery bypass graft (15) was done off pump and valve replacement (7) and atrial septal defect (2) were done on pump. " 01/01/2008 - "A beating-heart Ex-Maze procedure was performed in 54 AF patients (paroxysmal, n = 2; persistent, n = 11; longstanding persistent, n = 41) undergoing concomitant cardiac surgery (mitral valve replacement [MVR] = 23, aortic VR [AVR] = 7, coronary artery bypass graft [CABG] = 17, CABG +/- AVR = 3, CABG +/- MVR = 2, atrial-septal defect = 2). " 04/01/1995 - "Although no epidemiological studies are available to evaluate the exact risk of infective endocarditis complicating native cardiac disease, analysis of data in the literature shows that cardiac disease can be classified into three groups of decreasing risk: (1) high risk disease includes cyanotic congenital heart lesions, previous bacterial endocarditis, aortic valve disease, mitral regurgitation and uncorrected left-to-right shunt, but not atrial septal defect; (2) cardiac conditions of moderate risk include mitral valve prolapse with valvar regurgitation or leaflet thickening, isolated mitral stenosis, tricuspid valve disease, pulmonary stenosis and hypertrophic cardiomyopathy; (3) conditions of low or no risk include isolated atrial septal defect, ischaemic heart disease and/or previous coronary artery bypass graft surgery, surgically corrected left-to-right shunt with no residual shunt, mitral valve prolapse with thin leaflets in the absence of regurgitation, and calcification of the mitral annulus."
2.	Therapeutics 03/01/1995 - "Additional data that significantly altered surgical therapy was found in 12 of 48 patients (25%): proximal pulmonary artery thrombi (3), patent foramen ovale with significant right to left shunting (2), atrial septal defect (2), double-outlet right ventricle (2), ventricular septal defect (2), and exclusion of atrial septal defect (1). "
3.	Replantation 11/01/1978 - "Management of the LSVC during operative repair is usuall by one of three methods: (1) an intra-atrial baffle of pericardium to divery flow from the LSVC to the right arrium and to close the atrial septal defect; (2) division and reimplantation of the LSVC into the right atrium; or (3) simple ligation of the LSVC. "
4.	Ligation 11/01/1978 - "Management of the LSVC during operative repair is usuall by one of three methods: (1) an intra-atrial baffle of pericardium to divery flow from the LSVC to the right arrium and to close the atrial septal defect; (2) division and reimplantation of the LSVC into the right atrium; or (3) simple ligation of the LSVC. "
5.	Maze Procedure 01/01/2008 - "A beating-heart Ex-Maze procedure was performed in 54 AF patients (paroxysmal, n = 2; persistent, n = 11; longstanding persistent, n = 41) undergoing concomitant cardiac surgery (mitral valve replacement [MVR] = 23, aortic VR [AVR] = 7, coronary artery bypass graft [CABG] = 17, CABG +/- AVR = 3, CABG +/- MVR = 2, atrial-septal defect = 2). "